Navigation

Investiment.io
Financial analysis platform

Abbott Laboratories

ABT โ€ข NYSE

$107.45
โ–ผ1.07 (0.99%)โ€ข REGULAR

Abbott Laboratories

$107.45
โ–ผ1.0%
๐Ÿ“ŠSummary๐Ÿ“‹SEC Filings๐Ÿ‘ฅInsider Trading
๐Ÿ’ง

Cash Flow StatementABT

Cash Flow Summary

Key cash flow metrics and liquidity indicators for ABT

๐Ÿ”„
Operating Cash Flow
$9,566,000
(in thousands)
๐Ÿ’ฐ
Free Cash Flow
$7,395,000
(in thousands)
๐Ÿ—๏ธ
Capital Expenditures
-$2,171,000
(in thousands)
๐Ÿ“ˆ
Net Change in Cash
$906,000
(in thousands)

Cash Flow Analysis

Analyze operating, investing, and financing cash flows over time

Period:annual

Select Metrics to Compare (4 selected)

Net Operating Cash Flow Trend & Growth

Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025$0.00K$3.00B$6.00B$9.00B$12.00B-30%-15%0%+15%+30%
  • Net Operating Cash Flow
  • Net Operating Cash Flow YoY Growth

Free Cash Flow Trend & Growth

Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025$0.00K$2.50B$5.00B$7.50B$10.00B-40%-20%0%+20%+40%
  • Free Cash Flow
  • Free Cash Flow YoY Growth

Capital Expenditures Trend & Growth

Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025$-2.25B$-2.10B$-1.95B$-1.80B$-1.65B-24%-16%-8%0%+8%
  • Capital Expenditures
  • Capital Expenditures YoY Growth

Net Change in Cash Trend & Growth

Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025$-3.00B$-1.50B$0.00K$1.50B$3.00B-3750%-2500%-1250%0%+1250%
  • Net Change in Cash
  • Net Change in Cash YoY Growth